Mediclinic International PLC
LSE:MDC
P/B
Price to Book Value
Price to Book Value (P/B) ratio is a valuation multiple that measures the market's valuation of a company relative to its book value. The P/B ratio is only considered useful in practice when applied to capital-intensive businesses.
Market Cap | P/B | ||||
---|---|---|---|---|---|
UK |
Mediclinic International PLC
LSE:MDC
|
3.7B GBP | 1 | ||
US |
HCA Healthcare Inc
NYSE:HCA
|
84.8B USD | -52.5 | ||
SA |
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
103B SAR | 15.5 | ||
CN |
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
118.7B CNY | 6.3 | |
ZA |
L
|
Life Healthcare Group Holdings Ltd
JSE:LHC
|
15.6B Zac | 0 | |
ZA |
N
|
Netcare Ltd
JSE:NTC
|
15.1B Zac | 0 | |
BR |
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
|
69.2B BRL | 3.1 | ||
TH |
B
|
Bangkok Dusit Medical Services PCL
SET:BDMS
|
464.8B THB | 4.9 | |
US |
Tenet Healthcare Corp
NYSE:THC
|
12.6B USD | 3.6 | ||
US |
Universal Health Services Inc
NYSE:UHS
|
12B USD | 1.9 | ||
MY |
I
|
IHH Healthcare Bhd
KLSE:IHH
|
55B MYR | 1.9 |
P/B Forward Multiples
Forward P/B multiple is a version of the P/B ratio that uses forecasted equity for the P/B calculation. 1-Year, 2-Years, and 3-Years forwards use equity forecasts for 1, 2, and 3 years ahead, respectively.